Quick Reference Guide:
News Releases
March 03, 2010 - Anavex Comments on Failure of Pfizer and Medivation’s Alzheimer’s Investigational Drug Dimebon During Phase 3 Clinical Trials
January 19, 2010 - ANAVEX Appoints Dr. Cameron Durrant Executive Chairman of the Board
September 30, 2009 - ANAVEX Contracts FORENAP Pharma for Clinical Trials of ANAVEX 2-73 in Alzheimer's Disease
September 21, 2009 - Anavex Completes Scale-Up Manufacturing of ANAVEX 2-73 for Phase 1 Alzheimer's Disease Clinical Trials
August 27, 2009 - Anavex Reports Sigma Receptor Review Published in Leading Journal
August 11, 2009 - Anavex Announces Private Placement
April 09, 2009 - Anavex Receives $2.14 Million Capital Injection
April 08, 2009 - Pharmawire: Medivation, Anavex May Lower Oxidative Stress
February 10, 2009 - Anavex Appoints Leading Alzheimer’s Disease Expert Dr. Mark Smith to Scientific Advisory Board
January 30, 2009 - Anavex Scales Up Synthesis of ANAVEX 2-73 for Phase 1 Alzheimer’s Disease Study
December 17, 2008 - Ground-breaking Anti-amnesic and Neuroprotective Effects of Alzheimer's Compound Anavex 1-41 Published in Journal of Neuropsychopharmacology
December 04, 2008 - Anavex Presents Potent Neuroprotective Effects of Anavex 1-41 at Neuroscience 2008
September 02, 2008 - Anavex Completes Successful Preclinical Studies on Lead Alzheimer’s Drug Candidate
July 30, 2008 - Anavex Presents Neuroprotective Effects of Anavex 1-41 at the International Conference on Alzheimer’s Disease 2008
June 24, 2008 - Anavex Life Sciences Corp. will Present New Findings at the International Conference on Alzheimer’s Disease 2008 (July 26-31, 2008, Chicago, USA)
June 03, 2008 - Anavex Further Strengthens Board of Directors
May 20, 2008 - Anavex Announces Appointment of Oncology Specialist to Board of Directors, Changes to Executive Management
April 16, 2008 - Dr. Dimitri Goundis to Assist in Drug Development for Anavex
March 10, 2008 - Anavex 7-1037 Reduces Rate of Cancer Tumor Growth 69% in Pre-Clinical Studies, Compared to Currently Marketed Drug Dacarbazine Showing No Measurable Activity
January 22, 2008 - Anavex Outlines Corporate Milestones, Drug Advancement Plans for 2008
December 17, 2007 - Anavex Strengthens Board of Directors
December 06, 2007 - Anavex Advances Drug Candidates for Treatment of Epilepsy
November 28, 2007 - Anavex Advances Drug Candidate for Treatment of Alzheimer’s Disease
November 02, 2007 - Anavex Life Sciences Engages Primoris Group to Provide Investor Relations Services
Copyright @ 2001-2010 Primoris Group
Home | Services | News Releases | Media | Testimonials | Links | Contact Us